Histocompatibility testing for keratoplasty in high-risk patients

G. N. Foulks, F. P. Sanfilippo, J. A. Locascio, J. M. MacQueen, D. V. Dawson

Research output: Contribution to journalArticle

Abstract

Forty-eight consecutive patients at high risk for corneal graft rejection were transplanted with corneas from donors selected on the basis of a negative lymphocyte crossmatch, ABO blood group compatibility, and maximized HLA-A, -B matching. Graft survival in this study group was compared to a retrospective control group of 72 consecutive high-risk transplants performed in patients receiving randomly obtained corneal donors. Demographic parameters, cause of primary disease, and incidence of prior graft rejection were no different between the two groups. Graft survival at one year, calculated by the Kaplan-Meier method, was 78% for the negative crossmatch study group vs 52% in the uncrossmatched control group (P <0.05%). All graft failures in the negative crossmatch group were in poorly HLA matched recipients. While patients with evidence of nondonor specific humoral presensitization to HLA antigens experienced earlier graft rejection, overall graft survival was not associated with such nonspecific presensitization. These findings indicate that prospective histocompatibility testing can improve corneal allograft survival for high-risk patients by better identification of appropriate donors.

Original languageEnglish (US)
Pages (from-to)239-244
Number of pages6
JournalOphthalmology
Volume90
Issue number3
StatePublished - 1983
Externally publishedYes

Fingerprint

Histocompatibility Testing
Corneal Transplantation
Graft Rejection
Graft Survival
Tissue Donors
Transplants
Control Groups
HLA-A Antigens
HLA-B Antigens
Blood Group Antigens
HLA Antigens
Cornea
Allografts
Demography
Lymphocytes
Incidence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Foulks, G. N., Sanfilippo, F. P., Locascio, J. A., MacQueen, J. M., & Dawson, D. V. (1983). Histocompatibility testing for keratoplasty in high-risk patients. Ophthalmology, 90(3), 239-244.

Histocompatibility testing for keratoplasty in high-risk patients. / Foulks, G. N.; Sanfilippo, F. P.; Locascio, J. A.; MacQueen, J. M.; Dawson, D. V.

In: Ophthalmology, Vol. 90, No. 3, 1983, p. 239-244.

Research output: Contribution to journalArticle

Foulks, GN, Sanfilippo, FP, Locascio, JA, MacQueen, JM & Dawson, DV 1983, 'Histocompatibility testing for keratoplasty in high-risk patients', Ophthalmology, vol. 90, no. 3, pp. 239-244.
Foulks GN, Sanfilippo FP, Locascio JA, MacQueen JM, Dawson DV. Histocompatibility testing for keratoplasty in high-risk patients. Ophthalmology. 1983;90(3):239-244.
Foulks, G. N. ; Sanfilippo, F. P. ; Locascio, J. A. ; MacQueen, J. M. ; Dawson, D. V. / Histocompatibility testing for keratoplasty in high-risk patients. In: Ophthalmology. 1983 ; Vol. 90, No. 3. pp. 239-244.
@article{ce7380cf758d428aa633b3547dfd0758,
title = "Histocompatibility testing for keratoplasty in high-risk patients",
abstract = "Forty-eight consecutive patients at high risk for corneal graft rejection were transplanted with corneas from donors selected on the basis of a negative lymphocyte crossmatch, ABO blood group compatibility, and maximized HLA-A, -B matching. Graft survival in this study group was compared to a retrospective control group of 72 consecutive high-risk transplants performed in patients receiving randomly obtained corneal donors. Demographic parameters, cause of primary disease, and incidence of prior graft rejection were no different between the two groups. Graft survival at one year, calculated by the Kaplan-Meier method, was 78{\%} for the negative crossmatch study group vs 52{\%} in the uncrossmatched control group (P <0.05{\%}). All graft failures in the negative crossmatch group were in poorly HLA matched recipients. While patients with evidence of nondonor specific humoral presensitization to HLA antigens experienced earlier graft rejection, overall graft survival was not associated with such nonspecific presensitization. These findings indicate that prospective histocompatibility testing can improve corneal allograft survival for high-risk patients by better identification of appropriate donors.",
author = "Foulks, {G. N.} and Sanfilippo, {F. P.} and Locascio, {J. A.} and MacQueen, {J. M.} and Dawson, {D. V.}",
year = "1983",
language = "English (US)",
volume = "90",
pages = "239--244",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Histocompatibility testing for keratoplasty in high-risk patients

AU - Foulks, G. N.

AU - Sanfilippo, F. P.

AU - Locascio, J. A.

AU - MacQueen, J. M.

AU - Dawson, D. V.

PY - 1983

Y1 - 1983

N2 - Forty-eight consecutive patients at high risk for corneal graft rejection were transplanted with corneas from donors selected on the basis of a negative lymphocyte crossmatch, ABO blood group compatibility, and maximized HLA-A, -B matching. Graft survival in this study group was compared to a retrospective control group of 72 consecutive high-risk transplants performed in patients receiving randomly obtained corneal donors. Demographic parameters, cause of primary disease, and incidence of prior graft rejection were no different between the two groups. Graft survival at one year, calculated by the Kaplan-Meier method, was 78% for the negative crossmatch study group vs 52% in the uncrossmatched control group (P <0.05%). All graft failures in the negative crossmatch group were in poorly HLA matched recipients. While patients with evidence of nondonor specific humoral presensitization to HLA antigens experienced earlier graft rejection, overall graft survival was not associated with such nonspecific presensitization. These findings indicate that prospective histocompatibility testing can improve corneal allograft survival for high-risk patients by better identification of appropriate donors.

AB - Forty-eight consecutive patients at high risk for corneal graft rejection were transplanted with corneas from donors selected on the basis of a negative lymphocyte crossmatch, ABO blood group compatibility, and maximized HLA-A, -B matching. Graft survival in this study group was compared to a retrospective control group of 72 consecutive high-risk transplants performed in patients receiving randomly obtained corneal donors. Demographic parameters, cause of primary disease, and incidence of prior graft rejection were no different between the two groups. Graft survival at one year, calculated by the Kaplan-Meier method, was 78% for the negative crossmatch study group vs 52% in the uncrossmatched control group (P <0.05%). All graft failures in the negative crossmatch group were in poorly HLA matched recipients. While patients with evidence of nondonor specific humoral presensitization to HLA antigens experienced earlier graft rejection, overall graft survival was not associated with such nonspecific presensitization. These findings indicate that prospective histocompatibility testing can improve corneal allograft survival for high-risk patients by better identification of appropriate donors.

UR - http://www.scopus.com/inward/record.url?scp=0020597813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020597813&partnerID=8YFLogxK

M3 - Article

C2 - 6346199

AN - SCOPUS:0020597813

VL - 90

SP - 239

EP - 244

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 3

ER -